- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
Slow news weekend, so we'll post a story by Nathaniel Weixel of The Hill on his divination of GOP healthcare plans. Weixel isn't exactly a nonpartisan observer, even though he would like you to believe he is an independent journalist. So take his prognostications with a large lump of salt:
https://thehill.com/policy/healthcare/5624197-aca-subsidies-republican-options/
What’s on the GOP menu for ObamaCare reform, subsidy extensions
By Nathaniel Weixel - November 27, 2025Twenty-four million Americans are facing spiking health insurance prices because of expiring enhanced Affordable Care Act (ACA) subsidies that Republicans have so far refused to extend.
Lawmakers are divided on the way ahead, with the deadline to sign up for 2026 coverage on Dec. 15.
GOP leaders are faced with competing proposals across the House and Senate but the same political dilemma: Either they extend the subsidies and endorse ObamaCare, which Republicans have long opposed, or they let the subsidies expire ahead of next year’s midterms and deal with the electoral fallout.
Some want a deal to preserve the enhanced subsidies, heading off voter ire and preventing an election-year nightmare scenario for the GOP. Others want the enhanced subsidies to expire and be replaced by direct cash to Americans, convinced they can blame Democrats for high costs.
No matter what happens, the law’s underlying subsidies that help people afford premiums will continue past year’s end. But the expiration of the enhanced subsidies, enacted during the COVID-19 pandemic, means millions will see higher monthly payments.
Here’s what’s on the GOP menu, and who is behind it:
House front-line and moderate GOP
One bill comes from Reps. Don Bacon (R-Neb.), Tom Suozzi (D-N.Y.), Josh Gottheimer (D-N.J.), and Jeff Hurd (R-Colo.).
Their bill would extend ObamaCare’s enhanced subsidies for two years, along with some changes to try to assuage conservatives’ concerns about fraud.
The bill would extend the enhanced tax credits through 2027 for enrollees earning less than $200,000 per year for a family of four, and it would phase out the subsidies for enrollees earning between $200,000 and $300,000 for a family of four.
It would also create new guardrails to prevent “ghost beneficiaries” — ObamaCare enrollees who don’t have any health care claims. It’s one of the main criticisms Republicans have of the subsidies, and they argue it’s an indication of widespread fraud.
The bill would codify the federal government’s authority to remove bad actors from ACA marketplaces and require marketplaces to regularly confirm enrollee eligibility and that enrollees haven’t died.
The bill would also extend open enrollment to May 15 as a recognition that many would-be recipients may have been discouraged from purchasing health insurance by sticker shock over high premiums.
Separately, Bacon joined another small bipartisan group led by California Reps. Kevin Kiley (R) and Sam Liccardo (D) to back a two-year subsidy extension with an income cap that includes a pay-for. It seeks to create savings by cutting “excessive Medicare Advantage payouts to insurers” through the common practice of “upcoding.”
Rep. Jen Kiggans (R-Va.), who’s facing a tough reelection contest, has her own bill promoting a one-year extension. It’s been endorsed by 14 other GOP lawmakers.
Sen. Bill Cassidy (R-La)
The plan from Cassidy, chair of the Senate Health, Education, Labor and Pensions Committee, would let the enhanced subsidies expire.
Congress would then use that funding to deposit money directly into savings accounts (HSAs) for people who buy high-deductible plans on ObamaCare exchanges. The original subsidies would still go toward marketplace premiums.
Giving people HSAs has been a favorite idea among Republicans for years, and it was a key part of the party’s 2017 ACA replacement bills in the House and Senate. The idea appeals to Republicans who want to promote free market competition in health care.
Cassidy argued that offering HSA funds to a patient directly cuts out the insurer and empowers a patient to make their own choices for healthcare.
“We don’t have to be paternalistic,” he said during a recent Finance Committee hearing on health costs.
Cassidy’s plan is not the official Republican position, and he hasn’t released legislation yet. But it aligns with a demand by President Trump to end the enhanced subsidies and send money directly to consumers.
His idea takes advantage of a change made possible by the GOP’s One Big Beautiful Bill Act, which allowed ObamaCare “bronze” plans to be eligible for HSAs. Bronze plans feature lower premiums but high deductibles and only 60 percent coverage for medical expenses.
HSAs can’t be used to pay for monthly premiums, and critics argue that they won’t help if someone can’t afford the underlying cost in the first place. They also are of little help for someone with an expensive medical condition like cancer or diabetes.
Cassidy said he doesn’t have a cost estimate, and he hasn’t worked out how to allocate the HSAs to consumers.
Prior to the Thanksgiving recess, Cassidy said his goal was to have a plan ready to go by mid-December, which is when Senate GOP leaders promised Democrats they would hold a vote on extending the enhanced subsidies.
Sen. Rick Scott (R-Fla.)
Like Cassidy’s idea, Scott’s legislation centers on health savings accounts and would let the enhanced subsidies expire.
But his proposal goes even further than Cassidy’s and could undermine the entire structure of the Affordable Care Act.
Scott’s bill lets states submit a waiver to the federal government to replace the base ACA premium tax credits and instead fund “HSA-style Trump Health Freedom Accounts.”
Unlike traditional HSAs, people could use the funds to pay for both premiums and health expenses. According to the bill, the payments would be effective starting Jan. 1.
According to health research group KFF, the “freedom accounts” could be used for any type of health insurance plan, including short-term plans that can exclude people based on pre-existing conditions, which is not allowed under ObamaCare.
States could also waive certain provisions of the ACA, including the requirement to cover certain benefits. Scott’s plan would allow insurers to sell plans across state lines, opening up the possibility of selling plans that don’t meet a state’s regulatory requirements.
Scott’s plan could lead to a collapse of the ACA marketplace in states that fund the freedom accounts. Healthy people would be able to buy less expensive coverage or skip insurance altogether and use their accounts to pay for health care directly.
People with expensive health conditions would only be able to get coverage from ACA exchange plans.
The White House
President Trump has been sending conflicting messages.
Earlier this month, he posted an all-caps message on Truth Social telling Congress not to “waste your time and energy” on extending the subsidies.
But then a leaked White House plan reported by various outlets was closer to the House moderates’ idea than the ones from Cassidy or Scott.
It involved temporarily extending the ACA subsidies, potentially for two years, while incorporating a series of guardrails, like income eligibility limits and a requirement that all enrollees pay some form of premium. Both those policies seek to address the allegations of fraud.
It also reportedly would have included some incentives for enrollees to choose a high-deductible plan and redirect some federal aid into a health savings accounts.
Yet the apparent trial balloon popped soon after it was leaked. The reports sparked backlash from Republicans, who have spent years railing against the law.
On Nov. 25, Trump told reporters on Air Force One he’d “rather not” extend the subsidies.
“Somebody said I want to extend them for two years. I don’t want to extend them for two years.
I’d rather not extend them at all,” Trump said. “Some kind of extension may be necessary to get something else done, because the un-Affordable Care Act has been a disaster.”
"Premium Support" is the new Washington-speak for subsidies. The new terminology doesn't seem to convince GOP Senators that their constituents should pay for the rest of the country's (and the entire world's) health care:
https://thehill.com/homenews/senate/5628853-enhanced-health-subsidies-fight/
GOP pessimism grows over any deal to extend expiring health care subsidies
By Alexander Bolton - December 2, 2025Senate Republicans don’t see a bipartisan deal to extend enhanced health insurance premium subsidies coming together before the Christmas deadline, given the complexity of the issue and a growing fight over abortion, an issue that deeply divides both parties.
There is a solid group of Republican lawmakers in both the Senate and House who don’t want to see the enhanced subsidies under the Affordable Care Act (ACA) expire at the end of the month.
Many more, however, view ObamaCare as irretrievably broken, and an extension of beefed-up subsidies as policy heresy.
That fracture within the party makes it very difficult to move legislation and is a reason for the GOP pessimism.
Senate Majority Leader John Thune (R-S.D.) acknowledged the lack of progress Monday.
“My assumption is that by next week when we have to have that vote, that we might not be far enough along on the bipartisan discussions,” he told reporters.
Thune said the “conversations are still active on a solution,” but he warned “there are some significant sticking points.”
The GOP leader highlighted an escalating fight over adding language to any bill extending the subsidies to ensure federal money is not spent on abortion care.
“Dealing with Hyde is a big issue, obviously, for both sides,” Thune said, referring to language that prohibits taxpayers’ money being spent on abortions and is named after former Rep. Henry Hyde (R-Ill.).
Democrats argue that under current law, the subsidies do not fund abortions. But Republicans want stricter safeguards and to apply the Hyde Amendment, which prohibits federal funding of apportion, more directly to the health insurance marketplace.
Sen. Tammy Baldwin (Wis.), a leading Democratic voice on health care policy who has participated in Senate negotiations on the issue, said she does not support attaching new abortion-related language to federal insurance subsidies.
“When we enacted the ACA, there were safeguards related to the tax credits and they’ve been sufficient and they remain sufficient, to my mind. So I would not see supporting any additional limitations,” she said Monday while heading into the weekly Democratic leadership meeting.
“I’m certainly involved in the talks, always,” she added.
Sen. Elizabeth Warren (Mass.), another member of the Senate Democratic leadership team, said neither Senate Republican leaders nor the White House have presented any substantive proposals to keep the enhanced subsidies from expiring.
“There are no Republicans willing to negotiate over this. None. Where is Donald Trump? Where is the Republican leadership in the House or the Senate? None of them want to talk about health care assistance for American families,” she said.
“They don’t want to talk to the Democrats about that. They want to go off an engage in some fantasy conversation with each other about people who can afford to pay for health care. They have voted to cut health care, and they don’t want to reverse those cuts,” she added.
Senate Republican Whip John Barrasso (Wyo.) on Monday cast doubt on getting a bipartisan deal before Christmas, asserting Democrats haven’t yet agreed on a proposal to extend the subsidies.
“The Democrats haven’t even come up with a proposal. The House wants three years, someone wants a permanent extension — they don’t know what they want,” he said.
White House advisers last week floated a plan to extend the expiring subsidies temporarily while also reforming the program by imposing an income cap on individuals and families who qualify and cracking down on what Republicans say is rampant fraud.
But Trump last week distanced himself from the proposal after getting pushback from Speaker Mike Johnson (R-La.) and House conservatives.
“I’d rather not extend them at all,” Trump said shortly before Thanksgiving, though he acknowledged that “some kind of extension might be necessary to get something done.”
Speaker Johnson warned Trump advisers in a phone call last week that extending the enhanced ACA subsidies faced strong opposition within the House GOP conference.
Thune told reporters Monday that there’s interest among some Republican senators in extending the subsidies and reforming the ACA health insurance marketplace.
“We have a lot of interest on our side and a lot of good ideas that go back to try and address what we think are some of the underlying problems with ObamaCare in the first place. One being affordability, the fact that premiums continue to escalate year over year, and we think that has a lot to do with the way it’s structured and how it incentivizes insurance companies to cover people,” Thune said Monday evening.
Sen. Josh Hawley (R-Mo.) is warning that the expiration of enhanced subsidies would impact nearly half a million people in his home state.
“We can’t just allow the premium support to expire,” he warned last month.
Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy (R-La.) is working on legislation to convert the ACA’s premium tax credits into contributions to health savings accounts that could be used to defray out-of-pocket health care costs, according to an analysis of his plan by health care research nonprofit KFF.
That proposal has already run into Democratic opposition.
“We insist that the ACA tax credits have to be renewed and extended, period. If Cassidy’s proposal, as I understand it, replaces them, [that] looks like it’s privatizing health insurance, and looks like it’s really problematic,” Senate Democratic Leader Chuck Schumer (D-N.Y.) told reporters before the Thanksgiving recess.
House Democrats are circulating a discharge petition to force a vote in the lower chamber on legislation to extend the enhanced health insurance subsidies for three years.
But Republican leaders are skeptical that Democrats can get the 218 signatures to force a vote, and even if they prevail in the House, there’s no guarantee that legislation to extend the subsidies without significant reforms could get the 60 votes needed to pass the Senate.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















